Literature DB >> 11134304

Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

C L Parks1, R A Lerch, P Walpita, H P Wang, M S Sidhu, S A Udem.   

Abstract

Protein-encoding nucleotide sequences of the N, P, M, F, H, and L genes were determined for a low-passage isolate of the Edmonston wild-type (wt) measles virus and five Edmonston-derived vaccine virus strains, including AIK-C, Moraten, Schwarz, Rubeovax, and Zagreb. Comparative analysis demonstrated a high degree of nucleotide sequence homology; vaccine viruses differed at most by 0. 3% from the Edmonston wt strain. Deduced amino acid sequences predicted substitutions in all viral polypetides. Eight amino acid coding changes were common to all vaccine viruses; an additional two were conserved in all vaccine strains except Zagreb. Comparisons made between vaccine strains indicated that commercial vaccine lots of Moraten and Schwarz had identical coding regions and were closely related to Rubeovax, while AIK-C and Zagreb diverged from the Edmonston wt along slightly different paths. These comparisons also revealed amino acid coding substitutions in Moraten and Schwarz that were absent from the closely related reactogenic Rubeovax strain. All of the vaccine viruses contained amino acid coding changes in the core components of the virus-encoded transcription and replication apparatus. This observation, combined with identification of noncoding region nucleotide changes in potential cis-acting sequences of the vaccine strains (C. L. Parks, R. A. Lerch, P. Walpita, H.-P. Wang, M. S. Sidhu, and S. A. Udem, J. Virol. 75:921-933, 2001), suggest that modulation of transcription and replication plays an important role in attenuation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134304      PMCID: PMC113987          DOI: 10.1128/JVI.75.2.910-920.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Reverse Genetics Meets the Nonsegmented Negative-Strand RNA Viruses.

Authors: 
Journal:  Rev Med Virol       Date:  1997-04       Impact factor: 6.989

Review 2.  Mutations and A/I hypermutations in measles virus persistent infections.

Authors:  R Cattaneo; M A Billeter
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 3.  Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes.

Authors:  K K Conzelmann
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

4.  A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture.

Authors:  D Garcin; M Itoh; D Kolakofsky
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

5.  Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells.

Authors:  H Schneider; K Kaelin; M A Billeter
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

6.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

7.  Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level.

Authors:  C Escoffier; D Gerlier
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Chimeric measles viruses with a foreign envelope.

Authors:  P Spielhofer; T Bächi; T Fehr; G Christiansen; R Cattaneo; K Kaelin; M A Billeter; H Y Naim
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

Authors:  M H Skiadopoulos; S Surman; J M Tatem; M Paschalis; S L Wu; S A Udem; A P Durbin; P L Collins; B R Murphy
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm.

Authors:  M Huber; R Cattaneo; P Spielhofer; C Orvell; E Norrby; M Messerli; J C Perriard; M A Billeter
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  44 in total

1.  Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Measles virus C protein interferes with Beta interferon transcription in the nucleus.

Authors:  Konstantin M J Sparrer; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  A highly attenuated measles virus vaccine strain encodes a fully functional C protein.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

4.  Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses.

Authors:  Maino Tahara; Makoto Takeda; Yusuke Yanagi
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Measles vector as a multigene delivery platform facilitating iPSC reprogramming.

Authors:  Qi Wang; Alanna Vossen; Yasuhiro Ikeda; Patricia Devaux
Journal:  Gene Ther       Date:  2019-02-04       Impact factor: 5.250

6.  In vitro suppression of human immunodeficiency virus type 1 replication by measles virus.

Authors:  Mayra García; Xiao-Fang Yu; Diane E Griffin; William J Moss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Evolutionary dynamics of viral attenuation.

Authors:  Marty R Badgett; Alexandra Auer; Leland E Carmichael; Colin R Parrish; James J Bull
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.

Authors:  Makoto Takeda; Maino Tahara; Takao Hashiguchi; Takeshi A Sato; Fumiaki Jinnouchi; Shoko Ueki; Shinji Ohno; Yusuke Yanagi
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.

Authors:  Chantal Combredet; Valérie Labrousse; Lucile Mollet; Clarisse Lorin; Frédéric Delebecque; Bruno Hurtrel; Harold McClure; Mark B Feinberg; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.